Source: International Congress 2014 – Airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rainer, F. Haider, P. Marks, R. McCartney, J. Rezulski, S. Greenaway, G. MacGregor, G. Clarke (London, Glasgow, United Kingdom). Sputum processing methods in airway disease: Which is best?. Eur Respir J 2014; 44: Suppl. 58, 998

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014 Assessment of oxidative stress in cystic fibrosis using malondialdehyde Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study Source: International Congress 2014 – IPF and surroundings Year: 2014 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Mucus production, lung inflammation and functional decay in IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review Source: International Congress 2014 – Airway biomarkers Year: 2014 Small airways obstruction and exhaled particles in asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Asthma control is not related to large airways function Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Non-invasive evaluation of airway inflammation in non-CF bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Evaluation of three categorical sputum colour charts: is less more? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Sputum neutrophil differential cell count in health and relationship to disease severity in asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Surfactant protein expression at various COPD Gold stages Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014